Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedApr 13, 2026
DataAggregated Company Financials
Companies6
  • 7D0.7%
  • 3M-18.4%
  • 1Y-6.7%
  • YTD-14.0%

In the last week, the Life Sciences industry is flat overall, with Gerresheimer standing out by going down 8.0%. As for the longer term, the industry has declined 3.6% in the last year. Earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 13 Apr 2026€16.8b€7.6b€224.1m25.3x74.8x2.2x
Wed, 11 Mar 2026€17.3b€7.5b€168.6m29.3x102.5x2.3x
Fri, 06 Feb 2026€19.0b€7.5b€143.5m37.2x132.2x2.5x
Sun, 04 Jan 2026€19.5b€7.5b€143.5m41.1x135.7x2.6x
Tue, 02 Dec 2025€20.2b€7.5b€143.9m39.5x140x2.7x
Thu, 30 Oct 2025€20.1b€7.5b€147.4m42.7x136.7x2.7x
Sat, 27 Sep 2025€17.5b€7.4b€157.8m21x111x2.4x
Mon, 25 Aug 2025€18.6b€7.4b€157.8m25.1x118.2x2.5x
Wed, 23 Jul 2025€18.5b€7.4b€99.5m25.8x186.1x2.5x
Fri, 20 Jun 2025€20.3b€7.3b€114.9m28x176.9x2.8x
Sun, 18 May 2025€21.7b€7.3b€114.9m26.4x188.5x3x
Tue, 15 Apr 2025€18.3b€7.2b€125.5m25.4x146.1x2.5x
Thu, 13 Mar 2025€22.2b€7.1b€156.5m26.4x141.7x3.1x
Sat, 08 Feb 2025€23.5b€7.1b€169.8m24.2x138.4x3.3x
Mon, 06 Jan 2025€20.8b€7.1b€169.8m24.5x122.2x2.9x
Wed, 04 Dec 2024€21.7b€7.1b€170.5m27.6x127.5x3.1x
Fri, 01 Nov 2024€23.2b€7.1b€171.2m30.2x135.3x3.3x
Sun, 29 Sep 2024€24.9b€7.1b€172.8m31.1x144.2x3.5x
Tue, 27 Aug 2024€24.1b€7.0b€157.1m35.9x153.6x3.4x
Thu, 25 Jul 2024€24.1b€7.0b€237.1m37.2x101.8x3.4x
Sat, 22 Jun 2024€22.5b€7.0b€333.3m28.1x67.4x3.2x
Mon, 20 May 2024€26.6b€7.0b€340.1m30x78.2x3.8x
Wed, 17 Apr 2024€32.6b€7.1b€385.4m36.8x84.5x4.6x
Fri, 15 Mar 2024€34.0b€7.1b€384.5m37.5x88.3x4.8x
Sun, 11 Feb 2024€32.6b€7.3b€516.3m38.1x63.2x4.5x
Tue, 09 Jan 2024€30.8b€7.3b€507.1m35x60.8x4.2x
Thu, 07 Dec 2023€28.7b€7.3b€507.1m30.6x56.5x3.9x
Sat, 04 Nov 2023€26.3b€6.4b€356.1m39.4x74x4.1x
Mon, 02 Oct 2023€26.8b€6.6b€498.1m38.3x53.8x4.1x
Wed, 30 Aug 2023€30.1b€6.6b€425.8m43.5x70.7x4.6x
Fri, 28 Jul 2023€31.1b€6.6b€425.8m43.5x73.1x4.7x
Sun, 25 Jun 2023€26.8b€6.7b€487.3m38x55.1x4x
Tue, 23 May 2023€28.1b€6.7b€487.3m38.8x57.6x4.2x
Thu, 20 Apr 2023€30.3b€6.8b€595.6m35.4x50.9x4.5x
Price to Earnings Ratio

50.9x


Total Market Cap: €30.3bTotal Earnings: €595.6mTotal Revenue: €6.8bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 108.4x202420252026
Current Industry PE
  • Investors are pessimistic on the German Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 74.8x which is lower than its 3-year average PE of 108x.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 2.2x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 28% per year over the last three years.
  • Meanwhile revenues for these companies have grown 3.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market2.93%
Healthcare2.29%
Life Sciences0.69%
Clinical Research and Equipment0.69%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1SXP SCHOTT Pharma KGaA€13.921.6%
+€33.1m
-38.4%PE14x
EVT Evotec€4.530.6%
+€6.7m
-21.7%PS1x
FA0 PExA€0.01621.5%
+€347.6k
26.4%PS6.6x